Annual CFO
$1.27 B
-$446.00 M-25.96%
31 December 2023
Summary:
Quest Diagnostics Incorporated annual cash flow from operations is currently $1.27 billion, with the most recent change of -$446.00 million (-25.96%) on 31 December 2023. During the last 3 years, it has fallen by -$961.00 million (-43.04%). DGX annual CFO is now -43.04% below its all-time high of $2.23 billion, reached on 31 December 2021.DGX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$356.00 M
-$4.00 M-1.11%
30 September 2024
Summary:
Quest Diagnostics Incorporated quarterly cash flow from operations is currently $356.00 million, with the most recent change of -$4.00 million (-1.11%) on 30 September 2024. Over the past year, it has dropped by -$171.00 million (-32.45%). DGX quarterly CFO is now -58.70% below its all-time high of $862.00 million, reached on 30 September 2020.DGX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$1.40 B
+$149.00 M+11.94%
30 September 2024
Summary:
Quest Diagnostics Incorporated TTM cash flow from operations is currently $1.40 billion, with the most recent change of +$149.00 million (+11.94%) on 30 September 2024. Over the past year, it has increased by +$125.00 million (+9.83%). DGX TTM CFO is now -46.14% below its all-time high of $2.59 billion, reached on 30 June 2021.DGX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -32.5% | +9.8% |
3 y3 years | -43.0% | -26.0% | -37.4% |
5 y5 years | +2.3% | +2.3% | +12.4% |
DGX Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -43.0% | at low | -32.5% | +278.7% | -37.4% | +29.5% |
5 y | 5 years | -43.0% | +2.3% | -58.7% | +278.7% | -46.1% | +29.5% |
alltime | all time | -43.0% | +1537.5% | -58.7% | +3966.6% | -46.1% | +2694.0% |
Quest Diagnostics Incorporated Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $356.00 M(-1.1%) | $1.40 B(+11.9%) |
June 2024 | - | $360.00 M(+133.8%) | $1.25 B(-6.3%) |
Mar 2024 | - | $154.00 M(-70.8%) | $1.33 B(+4.7%) |
Dec 2023 | $1.27 B(-26.0%) | $527.00 M(+154.6%) | $1.27 B(+17.9%) |
Sept 2023 | - | $207.00 M(-53.4%) | $1.08 B(-21.5%) |
June 2023 | - | $444.00 M(+372.3%) | $1.37 B(+3.2%) |
Mar 2023 | - | $94.00 M(-71.9%) | $1.33 B(-22.5%) |
Dec 2022 | $1.72 B(-23.1%) | $334.00 M(-33.5%) | $1.72 B(-7.9%) |
Sept 2022 | - | $502.00 M(+24.9%) | $1.86 B(-3.1%) |
June 2022 | - | $402.00 M(-16.3%) | $1.92 B(-2.9%) |
Mar 2022 | - | $480.00 M(-0.2%) | $1.98 B(-11.2%) |
Dec 2021 | $2.23 B(+11.4%) | $481.00 M(-14.3%) | $2.23 B(-2.6%) |
Sept 2021 | - | $561.00 M(+22.0%) | $2.29 B(-11.6%) |
June 2021 | - | $460.00 M(-37.1%) | $2.59 B(+4.2%) |
Mar 2021 | - | $731.00 M(+35.1%) | $2.49 B(+24.1%) |
Dec 2020 | $2.00 B(+61.3%) | $541.00 M(-37.2%) | $2.00 B(+10.7%) |
Sept 2020 | - | $862.00 M(+142.8%) | $1.81 B(+45.1%) |
June 2020 | - | $355.00 M(+43.7%) | $1.25 B(+2.8%) |
Mar 2020 | - | $247.00 M(-29.0%) | $1.22 B(-2.3%) |
Dec 2019 | $1.24 B(+3.6%) | $348.00 M(+16.4%) | $1.24 B(+4.5%) |
Sept 2019 | - | $299.00 M(-6.9%) | $1.19 B(-8.0%) |
June 2019 | - | $321.00 M(+16.7%) | $1.29 B(-0.2%) |
Mar 2019 | - | $275.00 M(-6.8%) | $1.29 B(+7.9%) |
Dec 2018 | $1.20 B(+2.1%) | $295.00 M(-26.6%) | $1.20 B(-2.3%) |
Sept 2018 | - | $402.00 M(+24.5%) | $1.23 B(+3.4%) |
June 2018 | - | $323.00 M(+79.4%) | $1.19 B(+2.5%) |
Mar 2018 | - | $180.00 M(-44.3%) | $1.16 B(-1.4%) |
Dec 2017 | $1.18 B(+5.3%) | $323.00 M(-10.8%) | $1.18 B(-2.3%) |
Sept 2017 | - | $362.00 M(+23.1%) | $1.20 B(+5.3%) |
June 2017 | - | $294.00 M(+50.0%) | $1.14 B(-1.5%) |
Mar 2017 | - | $196.00 M(-44.2%) | $1.16 B(+3.9%) |
Dec 2016 | $1.12 B(+35.9%) | $351.00 M(+16.6%) | $1.12 B(+7.6%) |
Sept 2016 | - | $301.00 M(-3.2%) | $1.04 B(+9.4%) |
June 2016 | - | $311.00 M(+103.3%) | $948.00 M(+2.8%) |
Mar 2016 | - | $153.00 M(-43.8%) | $922.00 M(+12.3%) |
Dec 2015 | $821.00 M(-13.0%) | $272.00 M(+28.3%) | $821.00 M(-4.3%) |
Sept 2015 | - | $212.00 M(-25.6%) | $858.00 M(-6.4%) |
June 2015 | - | $285.00 M(+448.1%) | $917.00 M(+0.5%) |
Mar 2015 | - | $52.00 M(-83.2%) | $912.00 M(-3.4%) |
Dec 2014 | $944.00 M(+44.8%) | $309.00 M(+14.0%) | $944.00 M(+11.7%) |
Sept 2014 | - | $271.00 M(-3.2%) | $845.00 M(+11.0%) |
June 2014 | - | $280.00 M(+233.3%) | $761.00 M(+10.4%) |
Mar 2014 | - | $84.00 M(-60.0%) | $689.00 M(+5.7%) |
Dec 2013 | $652.00 M(-45.1%) | $210.00 M(+12.3%) | $652.00 M(-20.7%) |
Sept 2013 | - | $187.00 M(-10.1%) | $822.25 M(-20.2%) |
June 2013 | - | $208.00 M(+342.6%) | $1.03 B(-4.0%) |
Mar 2013 | - | $47.00 M(-87.6%) | $1.07 B(-9.6%) |
Dec 2012 | $1.19 B(+32.6%) | $380.25 M(-3.6%) | $1.19 B(+3.8%) |
Sept 2012 | - | $394.62 M(+57.3%) | $1.14 B(+5.2%) |
June 2012 | - | $250.87 M(+55.6%) | $1.09 B(+21.4%) |
Mar 2012 | - | $161.27 M(-52.2%) | $895.69 M(+0.1%) |
Dec 2011 | $895.00 M(-19.9%) | $337.27 M(-0.1%) | $895.00 M(-0.3%) |
Sept 2011 | - | $337.64 M(+467.4%) | $897.32 M(+0.9%) |
June 2011 | - | $59.50 M(-62.9%) | $889.75 M(-14.4%) |
Mar 2011 | - | $160.58 M(-52.7%) | $1.04 B(-7.0%) |
Dec 2010 | $1.12 B | $339.59 M(+2.9%) | $1.12 B(-1.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2010 | - | $330.07 M(+57.8%) | $1.14 B(-3.7%) |
June 2010 | - | $209.17 M(-12.6%) | $1.18 B(+22.7%) |
Mar 2010 | - | $239.22 M(-33.6%) | $963.87 M(-3.4%) |
Dec 2009 | $997.42 M(-6.2%) | $360.32 M(-3.5%) | $997.42 M(-0.3%) |
Sept 2009 | - | $373.54 M(-4157.2%) | $1.00 B(+4.7%) |
June 2009 | - | -$9.21 M(-103.4%) | $955.39 M(-18.9%) |
Mar 2009 | - | $272.76 M(-24.8%) | $1.18 B(+10.8%) |
Dec 2008 | $1.06 B(+14.7%) | $362.92 M(+10.3%) | $1.06 B(+0.7%) |
Sept 2008 | - | $328.92 M(+54.2%) | $1.06 B(+3.7%) |
June 2008 | - | $213.30 M(+35.1%) | $1.02 B(+9.1%) |
Mar 2008 | - | $157.91 M(-55.6%) | $933.28 M(+0.7%) |
Dec 2007 | $926.92 M(-2.6%) | $355.38 M(+22.0%) | $926.92 M(+5.6%) |
Sept 2007 | - | $291.20 M(+126.1%) | $877.64 M(+6.9%) |
June 2007 | - | $128.79 M(-15.0%) | $821.13 M(-4.8%) |
Mar 2007 | - | $151.55 M(-50.5%) | $862.79 M(-9.4%) |
Dec 2006 | $951.90 M(+11.8%) | $306.09 M(+30.4%) | $951.90 M(+0.3%) |
Sept 2006 | - | $234.69 M(+37.7%) | $949.22 M(+6.4%) |
June 2006 | - | $170.45 M(-29.2%) | $892.18 M(-6.7%) |
Mar 2006 | - | $240.66 M(-20.7%) | $956.21 M(+12.3%) |
Dec 2005 | $851.58 M(+6.6%) | $303.41 M(+70.8%) | $851.58 M(+4.9%) |
Sept 2005 | - | $177.66 M(-24.2%) | $811.75 M(-4.6%) |
June 2005 | - | $234.48 M(+72.4%) | $851.16 M(+3.3%) |
Mar 2005 | - | $136.03 M(-48.4%) | $824.12 M(+3.2%) |
Dec 2004 | $798.78 M(+20.5%) | $263.57 M(+21.4%) | $798.78 M(+0.2%) |
Sept 2004 | - | $217.08 M(+4.7%) | $797.49 M(+5.9%) |
June 2004 | - | $207.43 M(+87.4%) | $753.25 M(+5.3%) |
Mar 2004 | - | $110.69 M(-57.8%) | $715.19 M(+7.9%) |
Dec 2003 | $662.80 M(+11.1%) | $262.29 M(+51.8%) | $662.80 M(+2.4%) |
Sept 2003 | - | $172.84 M(+2.0%) | $646.96 M(+6.7%) |
June 2003 | - | $169.38 M(+190.5%) | $606.10 M(+0.7%) |
Mar 2003 | - | $58.30 M(-76.3%) | $601.82 M(+0.9%) |
Dec 2002 | $596.37 M(+28.0%) | $246.44 M(+86.7%) | $596.37 M(+15.9%) |
Sept 2002 | - | $131.98 M(-20.1%) | $514.45 M(-3.3%) |
June 2002 | - | $165.09 M(+212.4%) | $532.11 M(+11.3%) |
Mar 2002 | - | $52.85 M(-67.9%) | $477.93 M(+2.6%) |
Dec 2001 | $465.80 M(+26.1%) | $164.52 M(+9.9%) | $465.80 M(+9.8%) |
Sept 2001 | - | $149.65 M(+34.9%) | $424.28 M(+11.3%) |
June 2001 | - | $110.90 M(+172.3%) | $381.11 M(+1.1%) |
Mar 2001 | - | $40.73 M(-66.9%) | $377.03 M(+2.1%) |
Dec 2000 | $369.45 M(+48.1%) | $123.00 M(+15.5%) | $369.45 M(+19.4%) |
Sept 2000 | - | $106.48 M(-0.3%) | $309.45 M(-8.1%) |
June 2000 | - | $106.82 M(+222.2%) | $336.88 M(+30.0%) |
Mar 2000 | - | $33.16 M(-47.4%) | $259.06 M(+3.8%) |
Dec 1999 | $249.50 M(+76.4%) | $63.00 M(-52.9%) | $249.50 M(+11.7%) |
Sept 1999 | - | $133.90 M(+361.7%) | $223.40 M(+46.2%) |
June 1999 | - | $29.00 M(+22.9%) | $152.80 M(+12.0%) |
Mar 1999 | - | $23.60 M(-36.0%) | $136.40 M(-3.5%) |
Dec 1998 | $141.40 M(-19.8%) | $36.90 M(-41.7%) | $141.40 M(-1.0%) |
Sept 1998 | - | $63.30 M(+402.4%) | $142.90 M(+4.3%) |
June 1998 | - | $12.60 M(-55.9%) | $137.00 M(-11.6%) |
Mar 1998 | - | $28.60 M(-25.5%) | $154.90 M(-12.1%) |
Dec 1997 | $176.30 M(-299.2%) | $38.40 M(-33.1%) | $176.30 M(+27.8%) |
Sept 1997 | - | $57.40 M(+88.2%) | $137.90 M(+71.3%) |
June 1997 | - | $30.50 M(-39.0%) | $80.50 M(+61.0%) |
Mar 1997 | - | $50.00 M | $50.00 M |
Dec 1996 | -$88.49 M | - | - |
FAQ
- What is Quest Diagnostics Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly CFO year-on-year change?
- What is Quest Diagnostics Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated TTM CFO year-on-year change?
What is Quest Diagnostics Incorporated annual cash flow from operations?
The current annual CFO of DGX is $1.27 B
What is the all time high annual CFO for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual cash flow from operations is $2.23 B
What is Quest Diagnostics Incorporated quarterly cash flow from operations?
The current quarterly CFO of DGX is $356.00 M
What is the all time high quarterly CFO for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly cash flow from operations is $862.00 M
What is Quest Diagnostics Incorporated quarterly CFO year-on-year change?
Over the past year, DGX quarterly cash flow from operations has changed by -$171.00 M (-32.45%)
What is Quest Diagnostics Incorporated TTM cash flow from operations?
The current TTM CFO of DGX is $1.40 B
What is the all time high TTM CFO for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high TTM cash flow from operations is $2.59 B
What is Quest Diagnostics Incorporated TTM CFO year-on-year change?
Over the past year, DGX TTM cash flow from operations has changed by +$125.00 M (+9.83%)